EE200100082A - Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud rakkude ebaloomuliku proliferatsiooni raviks laiaspektrilise ravimresistentsusega P-glükoproteiini ekspresseerivates rakuliinides - Google Patents

Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud rakkude ebaloomuliku proliferatsiooni raviks laiaspektrilise ravimresistentsusega P-glükoproteiini ekspresseerivates rakuliinides

Info

Publication number
EE200100082A
EE200100082A EEP200100082A EEP200100082A EE200100082A EE 200100082 A EE200100082 A EE 200100082A EE P200100082 A EEP200100082 A EE P200100082A EE P200100082 A EEP200100082 A EE P200100082A EE 200100082 A EE200100082 A EE 200100082A
Authority
EE
Estonia
Prior art keywords
glycoprotein
medicament
broad
resistant
preparation
Prior art date
Application number
EEP200100082A
Other languages
English (en)
Inventor
Bissery Marie-Christine
Vrignaud Patricia
Roberts Simon
Brealey Clive
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98115650A external-priority patent/EP0982028A1/en
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of EE200100082A publication Critical patent/EE200100082A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200100082A 1998-08-20 1999-08-18 Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud rakkude ebaloomuliku proliferatsiooni raviks laiaspektrilise ravimresistentsusega P-glükoproteiini ekspresseerivates rakuliinides EE200100082A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98115650A EP0982028A1 (en) 1998-08-20 1998-08-20 New use of taxoid derivatives
US12384399P 1999-03-11 1999-03-11
PCT/EP1999/006292 WO2000010547A2 (en) 1998-08-20 1999-08-18 New use of taxoid derivatives

Publications (1)

Publication Number Publication Date
EE200100082A true EE200100082A (et) 2002-06-17

Family

ID=26149552

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100082A EE200100082A (et) 1998-08-20 1999-08-18 Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud rakkude ebaloomuliku proliferatsiooni raviks laiaspektrilise ravimresistentsusega P-glükoproteiini ekspresseerivates rakuliinides

Country Status (15)

Country Link
EP (1) EP1105119A2 (et)
JP (1) JP2002523364A (et)
KR (1) KR20010079665A (et)
CN (1) CN1313764A (et)
AU (1) AU5742099A (et)
BG (1) BG105273A (et)
CA (1) CA2341191A1 (et)
EE (1) EE200100082A (et)
HU (1) HUP0104000A3 (et)
IL (1) IL141231A0 (et)
MX (1) MXPA01001721A (et)
NO (1) NO20010655D0 (et)
SK (1) SK2352001A3 (et)
TR (1) TR200100575T2 (et)
WO (1) WO2000010547A2 (et)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2922107B1 (fr) * 2007-10-10 2010-02-26 Aventis Pharma Sa Nouvelles compositions a base de taxoides
CN102770131A (zh) 2009-10-29 2012-11-07 安万特医药股份有限公司 卡巴他赛的新颖抗肿瘤用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697522B1 (fr) * 1992-10-30 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
FR2732968B1 (fr) * 1995-04-14 1997-05-16 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
MXPA01001721A (es) 2005-06-03
HUP0104000A3 (en) 2003-01-28
EP1105119A2 (en) 2001-06-13
HUP0104000A2 (hu) 2002-04-29
BG105273A (en) 2001-11-30
WO2000010547A2 (en) 2000-03-02
IL141231A0 (en) 2002-03-10
CA2341191A1 (en) 2000-03-02
TR200100575T2 (tr) 2001-07-23
WO2000010547A3 (en) 2000-06-29
CN1313764A (zh) 2001-09-19
AU5742099A (en) 2000-03-14
JP2002523364A (ja) 2002-07-30
NO20010655L (no) 2001-02-07
NO20010655D0 (no) 2001-02-07
SK2352001A3 (en) 2001-07-10
KR20010079665A (ko) 2001-08-22

Similar Documents

Publication Publication Date Title
IL146119A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
EE200000770A (et) Farnesüülproteiintransferaasi inhibiitorite kasutamine farmatseutilise kompositsiooni valmistamiseks, mis on ette nähtud artropaatiate raviks
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
EE200200343A (et) Asaindooli sisaldav farmatseutiline kompositsioonraviotstarbeliseks kasutamiseks, asaindoolid ningnende kasutamine ravimite valmistamiseks, mis on ette nähtud proteiinikinaasi katalüütilise toime pärssimiseks
EP1178786A4 (en) PHARMACOLOGICALLY ACTIVE PROTEIN STABILIZING AGENTS; METHODS OF MANUFACTURE AND METHODS OF USE
EE200000253A (et) Seentevastase toimeaine kasutamine ravimite valmistamiseks, mis on ette nähtud mitteinvasiivsetest seenorganismidest tingitud haiguste raviks või vältimiseks
EE04851B1 (et) 4H-1-bensopüraan-4-ooni derivaatide kasutamine ravimi valmistamiseks silelihasrakkude proliferatsiooni inhibeerimiseks
HUP0203403A3 (en) New imidazole derivatives, pharmaceutical compositions containing them and their use
DE69923076D1 (de) Transthorakale arzneimittelabgabevorrichtung
DK1204410T3 (da) Farmaceutisk doseringsform med flere komponenter
BR0014929B1 (pt) dispositivo para distribuiÇço de medicamento oftÁlmico.
NO20014013L (no) 16-halogen-epotilonderivater, fremgangsmåter for fremstilling av disse og farmasöytisk anvendelse av dem
ATE251625T1 (de) 8-phenyl-6,9-dihydro-(1,2,4)triazolo(3,4-i)puri - 5-on derivate
NO991815D0 (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
MXPA03000753A (es) Derivados de benzimidazola, su preparacion y su aplicacion terapeutica.
HUP0301333A3 (en) Pharmaceutical superdisintegrant, process for its preparation and its use
EE200200214A (et) Dipüridamooli või mopidamooli kasutamine sellise ravimi valmistamiseks, mis on ette nähtud fibriinsõltuvate mikrotsirkulatsiooni häirete ennetamiseksja raviks
EE05056B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
PT1071433E (pt) 2',2'-difluoronuecleosidos para terapia imunossupressora e preparados farmaceuticos combinados
IL137186A0 (en) Device for inhaling medicament
EE04903B1 (et) Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette n„htud rakkude ebaloomuliku proliferatsiooni raviks imetajate ajus
IT1287174B1 (it) Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
EE05415B1 (et) Ravimi manustamise vahend, eriti androgeenide manustamiseks
HUP0203539A3 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
FR2775901B1 (fr) Sels de cetoacides et de derives amines, et leur utilisation pour la preparation de medicaments